SureTouch Awarded Prestigious 2014 Patrick Soon-Shiong Innovation Award by the Los Angeles Business Journal

SureTouch Awarded Prestigious 2014 Patrick Soon-Shiong Innovation Award by the Los Angeles Business Journal

LOS ANGELES, CALIFORNIA – November 19th, 2014 – Medical Tactile Inc. (MTI), manufacturer of SureTouch, a screening device for breast cancer detection, today announced today that it is the recipient of the Los Angeles Business Journal's 2014 Patrick Soon-Shiong Innovation Award. The prestigious honor celebrates organizations that stretch boundaries and advance the innovative and economic competitiveness of the Los Angeles region.

Fifteen finalists were selected this year to compete for five awards. An independent judging panel named the 2014 recipients and the award was handed out to SureTouch at a ceremony on November 18th, 2014 at the Four Seasons Hotel Los Angeles in Beverly Hills.

“We are proud to be named among the innovative companies recognized for an award whose primary purpose is to honor companies that try to make the world a better place by thinking differently. The award marks another milestone in our long journey for making SureTouch the standard of care for breast cancer screening and fulfilling its mission to deliver more accurate breast cancer detection without pain or radiation at significantly lower cost.” said Dr. Jae Son, Chairman and Interim CEO of MTI.

Dr. Son Receives Patrick Soon-Shiong 2014 Innovation Award

About SureTouch™ 
SureTouch is a FDA-cleared device utilizing tactile imaging technology to detect breast cancer. The SureTouch Breast Exam is a simple procedure using a hand-held device that captures a graphic representation of an amplified map of breast tissue. With SureTouch, the patient and the doctor can view the size, shape, hardness and location of suspicious masses immediately during the examination and masses as small as 5mm can be identified, thus facilitating immediate and potentially life-saving actions. While 80 percent of newly diagnosed breast cancers are found by the sense of touch, SureTouch is far more sensitive than human touch and can detect smaller lesions than a trained clinician.  Women love SureTouch because it is pain free, radiation free and provides immediate results. SureTouch is effective with younger women and older women even with fibrous breast tissue. Because SureTouch is safe, women are encouraged to get examined more frequently. 

 About The Patrick Soon-Shiong Innovation Awards

One of the wealthiest people in Los Angeles, and a past recipient of the LABJ's Business Person of the Year, Dr. Patrick Soon-Shiong's groundbreaking concepts for curing diabetes led to the first nanotechnology-based breast cancer drug, Abraxane, which is credited with saving thousands of lives. Now, for the fifth year, his love of innovation has prompted him to again join the Business Journal in handing out the Patrick Soon-Shiong Innovation Awards to deserving organizations.

For more information, visit our website at or contact:

Jae Son, Ph.D., Chairman and Interim CEO
Medical Tactile, Inc.